• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev and Lantern Form Strategic Partnership to Enhance Surgical Cost Transparency and Positively Impact Care Quality and Cost Savings

    5/7/25 8:00:00 AM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email

    The partnership integrates Claritev's innovative solutions with Lantern's Specialty Care Platform to optimize healthcare costs for Lantern's footprint.

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced an agreement with Lantern, a Specialty Care Platform that helps employers reduce costs and improve health outcomes for surgery, cancer and infusions care. This strategic partnership brings together Claritev's award-winning BenInsights® and HST Connect® solutions with Lantern's Network of Excellence and TrueRateTM savings methodology to create a powerful solution for healthcare cost optimization that ultimately lowers costs in the healthcare ecosystem.

    This collaboration builds upon previous joint research, enabling Claritev and Lantern to provide enhanced value to employers, as well as the healthcare services that patients receive through data-driven surgical cost analysis and healthcare cost optimization.

    "This partnership is another step forward in Claritev's transformation journey," said Travis Dalton, Chairman, CEO and President of Claritev. "Lantern shares the same commitment as Claritev - to improve healthcare affordability and transparency in the U.S. Our previous collaboration with them on surgical episode costs reinforced what an impactful partnership this is, and we look forward to delivering meaningful savings for employer groups while increasing the quality of care a patient receives."

    Claritev and Lantern will combine Claritev's data capabilities with Lantern's surgical bundling methodology to provide enhanced value through validated cost optimization opportunities in two ways:

    • Enhanced Data Analytics with BenInsights – Claritev's comprehensive platform unifies financial and clinical data to deliver a 360-degree view of healthcare spending patterns and benefit plan design through configurable reporting and Smart Card technology. With added access to Lantern's surgical network, BenInsights will provide clients with unprecedented visibility into surgical cost variations and concrete opportunities for optimized care pathways and substantial savings.
    • Optimized Patient Steering with HST Connect – Claritev's HST Connect will integrate Lantern's surgical network and services to help guide patients to high-quality, cost-effective providers to enhance patient experience and improve patient care.

    "Surgery is 20% of an employer's health spend, but the pricing for those episodes has been nearly impossible to unpack. We published our TrueRateTM savings methodology to increase transparency and encourage the market to adopt our repeatable formula as the new industry standard," said Dickon Waterfield, President of Lantern. "Our partnership with Claritev allows us to transform those innovative insights into actionable tools that will deliver even more specialty care cost savings for our clients."

    About Claritev

    Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design in healthcare. By developing purpose-built solutions that support all key stakeholders — including payors, employers, patients, providers and third parties — Claritev is dedicated to making healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    About Lantern

    Lantern is the specialty care platform connecting people with the best care when they need it most. By curating a Network of Excellence comprised of the nation's top specialists for surgery, cancer care, infusions and more, Lantern delivers excellent care with significant cost savings to employers and their workforces. Lantern also pairs members with a dedicated care team, including Care Advocates and nurses, for the entirety of their care journey, helping them get back to good health, back to their families and back to work. With convenient access to specialists nationwide, Lantern means quality care is within driving distance for most. Lantern is trusted by the nation's largest employers to deliver care to more than 6 million members across the country. Learn more about us at lanterncare.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250506543825/en/

    Claritev Media Relations

    Pamela Walker

    VP, Corporate Marketing

    Claritev

    781-895-3118

    [email protected]



    Claritev Investor Relations

    Jason Wong

    SVP, Treasury & Investor Relations

    Claritev

    866-909-7427

    [email protected]



    Shawna Gasik

    AVP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    1/12/2026$43.00Buy
    Guggenheim
    1/9/2026$33.00Equal Weight
    Wells Fargo
    10/21/2025$74.00Neutral → Buy
    Citigroup
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief People Officer Carol Nutter was granted 1,884 shares, increasing direct ownership by 7% to 30,748 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    2/20/26 4:10:38 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael was granted 2,444 shares, increasing direct ownership by 2% to 107,973 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    2/20/26 4:09:52 PM ET
    $CTEV
    Real Estate

    SVP, General Counsel O'Neil Tara was granted 1,421 shares, increasing direct ownership by 6% to 26,449 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    2/20/26 4:09:15 PM ET
    $CTEV
    Real Estate

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results

    Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh

    2/23/26 4:05:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following

    1/29/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation to Present at J.P. Morgan Healthcare Conference

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced its participation in the 44th Annual J.P. Morgan Healthcare Conference. Management will be presenting on Thursday, January 15, 2026 at 7:30 a.m. PT. A live webcast and audio archive of the presentation will be available through the investor relations section of Claritev's website at investors.claritev.com/events-and-presentations. For one-on-one meetings, please contact a representative at the host firm. About Claritev Claritev is a healthcare technology, data and insights company focused on im

    1/6/26 5:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Guggenheim initiated coverage on Claritev with a new price target

    Guggenheim initiated coverage of Claritev with a rating of Buy and set a new price target of $43.00

    1/12/26 8:12:35 AM ET
    $CTEV
    Real Estate

    Wells Fargo initiated coverage on Claritev with a new price target

    Wells Fargo initiated coverage of Claritev with a rating of Equal Weight and set a new price target of $33.00

    1/9/26 9:03:34 AM ET
    $CTEV
    Real Estate

    Claritev upgraded by Citigroup with a new price target

    Citigroup upgraded Claritev from Neutral to Buy and set a new price target of $74.00

    10/21/25 7:13:03 AM ET
    $CTEV
    Real Estate

    $CTEV
    SEC Filings

    View All

    Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    2/23/26 4:14:07 PM ET
    $CTEV
    Real Estate

    Claritev Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    1/15/26 7:47:34 AM ET
    $CTEV
    Real Estate

    Claritev Corporation filed SEC Form 8-K: Leadership Update

    8-K - Claritev Corp (0001793229) (Filer)

    12/29/25 4:06:07 PM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., CEO & Executive Chair Dalton Travis bought $249,842 worth of shares (5,290 units at $47.23) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/20/25 5:57:08 PM ET
    $CTEV
    Real Estate

    SVP, Chief Strategy Officer Mintz William B. bought $34,808 worth of shares (916 units at $38.00), increasing direct ownership by 1% to 65,325 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/19/25 4:34:04 PM ET
    $CTEV
    Real Estate

    EVP, Chief Digital Officer Kim Michael bought $367,199 worth of shares (9,600 units at $38.25), increasing direct ownership by 10% to 105,529 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    11/18/25 4:23:08 PM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports Fourth Quarter and Full Year 2025 Results

    Q4 2025 Revenues of $246.6 million, Net loss of $80.6 million, and Adjusted EBITDA of $151.3 million (Adjusted EBITDA Margin of 61.4%) Full-year 2025 Revenues of $965.4 million (increase of 3.7% compared to FY 2024), Net loss of $284.3 million, and Adjusted EBITDA of $602.6 million (increase of 4.5% compared to FY 2024) Full-year 2026 Guidance initiated: Revenue range of $980 million to $1 billion Free cash flow of $0 million to $10 million Capital expenditures of $160 million to $170 million Company Board of Directors approves $75 million, five-year share repurchase program Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insigh

    2/23/26 4:05:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its fourth quarter and fiscal year 2025 financial results after market close on Monday, February 23, 2026, and hold a conference call at 4:30 pm Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following

    1/29/26 8:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate